| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |